Sodium-Glucose Cotransporter 2 Inhibitors Significantly Lower the Cardiac Electrophysiological Balance Index in Type 2 Diabetes Patients

被引:1
作者
Ozdemir, Emrah [1 ]
Ziyrek, Murat [1 ]
Donmez, Esra [1 ]
Ozcan, Sevgi [1 ]
Ince, Orhan [1 ]
Gevher, Ceyla Zeynep Colakoglu [3 ]
Ozdemir, Bahar [4 ]
Okuyan, Ertugrul [2 ]
机构
[1] Biruni Univ, Fac Med, Dept Cardiol, Istanbul, Turkiye
[2] Bagcilar Training & Res Hosp, Dept Cardiol, Istanbul, Turkiye
[3] Kanuni Sultan Suleyman Training & Res Hosp, Dept Cardiol, Istanbul, Turkiye
[4] Dr Sadi Konuk Training & Res Hosp, Dept Internal Med, Istanbul, Turkiye
来源
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY | 2025年 / 53卷 / 02期
关键词
Arrhythmia; diabetes mellitus; index of cardiac electrophysiological balance sodium-glucose cotransporter 2; ATRIAL-FIBRILLATION; SGLT2; INHIBITORS; VENTRICULAR-ARRHYTHMIAS; HEART-FAILURE; RISK; METAANALYSIS; POPULATION; DISPERSION; BIOMARKER; MELLITUS;
D O I
10.5543/tkda.2024.07280
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Sodium-glucose cotransporter 2 (SGLT2) inhibitors, a novel group of oral antidiabetic drugs, have demonstrated cardioprotective benefits and positive metabolic effects in patients with diabetes mellitus (DM). The cardiac electrophysiological balance index (ICEB) is an eletrocardiographic ratio that provides information about the equilibrium between left ventricular depolarization and repolarization duration, offering valuable insights into the predisposition to ventricular arrhythmias. The aim of this study is to analyze the potential impact of SGLT2 inhibitors on ICEB. Method: Patients were prospectively selected from a pool of 2,789 consecutive type 2 DM patients. After exclusions, 174 patients formed the monotherapy group, and 143 age- and sex-matched patients who were switched to SGLT2 inhibitor combination therapy constituted the combination therapy group. All treatment changes were supervised by endocrinologists blinded to the patient groups. Baseline and six-month electrocardiogram (ECG) data of both groups were analyzed. ICEB was defined as QT/QRS, and ICEBc as QTc/QRS. Results: Although there was no statistically significant difference between the monotherapy and combination therapy groups in terms of baseline ECG parameters, QT (385.05 +/- 13.21 vs. 372.32 +/- 4.32; P < 0.001), QTc (409.24 +/- 8.17 vs. 383.72 +/- 7.24; P < 0.001), ICEB (4.15 +/- 0.51 vs. 4.03 +/- 0.54; P = 0.004), and ICEBc (4.40 +/- 0.75 vs. 4.16 +/- 0.61; P < 0.0001) values at the six-month mark were significantly lower in the SGLT2 inhibitor group. Conclusion: SGLT2 inhibitors significantly lower ICEB and ICEBc, potentially reducing ventricular susceptibility to arrhythmias as early as six months into treatment for diabetic patients.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 29 条
  • [1] Alsancak Y, 2019, J Surg Med., V3, P223, DOI [10.28982/josam.485247, DOI 10.28982/JOSAM.485247]
  • [2] Alsancak Y, 2019, Selcuk Med J, V35, P169
  • [3] Index of cardiac-electrophysiological balance and the effects of thrombolytic therapy on the electrocardiogram of patients with pulmonary embolism
    Alsancak, Yakup
    Sahin, Ahmet Taha
    Gurbuz, Ahmet Seyfeddin
    Sertdemir, Ahmet Lutfi
    Icli, Abdullah
    Akilli, Hakan
    Duzenli, Mehmet Akif
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (12): : 1657 - 1665
  • [4] Dispersion of ventricular repolarization and refractory period
    Burton, FL
    Cobbe, SM
    [J]. CARDIOVASCULAR RESEARCH, 2001, 50 (01) : 10 - 23
  • [5] Current Use of Sodium Glucose Co-transporter 2 Inhibitors in Heart Failure Therapy
    Cavusoglu, Yuksel
    Altay, Hakan
    Celik, Ahmet
    Guvenc, Tolga Sinan
    Kilicarslan, Baris
    Nalbantgil, Sanem
    Temizhan, Ahmet
    Yildirimturk, Ozlem
    Yilmaz, Mehmet Birhan
    [J]. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2024, 52 (06): : 429 - 454
  • [6] Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
    Curtain, James P.
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Petrie, Mark C.
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Bengtsson, Olof
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Solomon, Scott D.
    McMurray, John J., V
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (36) : 3727 - 3738
  • [7] Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study
    Dahlqvist, Sofia
    Rosengren, Annika
    Gudbjornsdottir, Soffia
    Pivodic, Aldina
    Wedel, Hans
    Kosiborod, Mikhail
    Svensson, Ann-Marie
    Lind, Marcus
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (10) : 799 - 807
  • [8] Diabetic Cardiomyopathy What Is It and Can It Be Fixed?
    Dillmann, Wolfgang H.
    [J]. CIRCULATION RESEARCH, 2019, 124 (08) : 1160 - 1162
  • [9] Effects of SGLT2 Inhibitors as an Add-on Therapy to Metformin on Electrocardiographic Indices of Ventricular Repolarization
    Duran, Mustafa
    Ziyrek, Murat
    Alsancak, Yakup
    [J]. ACTA CARDIOLOGICA SINICA, 2020, 36 (06) : 626 - 632
  • [10] Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials
    Fernandes, Gilson C.
    Fernandes, Amanda
    Cardoso, Rhanderson
    Penalver, Jorge
    Knijnik, Leonardo
    Mitrani, Raul D.
    Myerburg, Robert J.
    Goldberger, Jeffrey J.
    [J]. HEART RHYTHM, 2021, 18 (07) : 1098 - 1105